Impact of lesion calcification on angiographic outcomes after Absorb everolimus-eluting bioresorbable vascular scaffold implantation: an observation from the ABSORB Japan trial
Masanobu Ohya(Kurashiki Central Hospital), Takeshi Kimura(Municipal Hirakata City Hospital), Hajime Kusano, Yoshinobu Onuma(Ollscoil na Gaillimhe – University of Galway), Masaaki Uematsu(University of Pisa), Tomohiro Kawasaki(Koga Hospital), Gregg W. Stone(Cardiovascular Institute of the South), Yohei Sotomi(Kyoto University), Patrick W. Serruys(Erasmus MC), Kazushige Kadota(Kurashiki Central Hospital), Kōichi Nakao(Kanazawa Seiryo University), Ken Kozuma(Teikyo University Hospital), Shih‐Wa Ying, Kouichi Tachibana(Tokai University), Kengo Tanabe, Yoshisato Shibata, Jeffery J. Popma, Tetsuya Tobaru(Sakakibara Hospital), Koichi Kishi(Kyoto Medical Center), Yoshihiro Morino(Iwate Medical University)
Cited by 7
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k